FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213309951> ?p ?o ?g. }

• W4213309951 endingPage "1137" @default.
• W4213309951 startingPage "1128" @default.
• W4213309951 abstract "The tryptophan-kynurenine (KYN) pathway is linked to obesity-related systemic inflammation and metabolic health. The pathway generates multiple metabolites, with little available data on their relationships to early markers of increased metabolic disease risk in children. The aim of this study was to examine the association of multiple KYN pathway metabolites with metabolic risk markers in prepubertal Asian children.Fasting plasma concentrations of KYN pathway metabolites were measured using liquid chromatography-tandem mass spectrometry in 8-year-old children (n = 552) from the Growing Up in Singapore Towards healthy Outcomes (GUSTO) prospective mother-offspring cohort study. The child's weight and height were used to ascertain overweight and obesity using local body mass index (BMI)-for-age percentile charts. Body fat percentage was measured by quantitative magnetic resonance. Abdominal circumference, systolic and diastolic blood pressure, homeostatic model assessment for insulin resistance (HOMA-IR), triglyceride, and HDL-cholesterol were used for the calculation of Metabolic syndrome scores (MetS). Serum triglyceride, BMI, gamma-glutamyl transferase (GGT), and abdominal circumference were used in the calculation of the Fatty liver index (FLI). Associations were examined using multivariable regression analyses.In overweight or obese children (n = 93; 16.9% of the cohort), all KYN pathway metabolites were significantly increased, relative to normal weight children. KYN, kynurenic acid (KA), xanthurenic acid (XA), hydroxyanthranilic acid (HAA) and quinolinic acid (QA) all showed significant positive associations with body fat percentage (B(95% CI) = 0.32 (0.22,0.42) for QA), HOMA-IR (B(95% CI) = 0.25 (0.16,0.34) for QA), and systolic blood pressure (B(95% CI) = 0.14(0.06,0.22) for QA). All KYN metabolites except 3-hydroxykynurenine (HK) significantly correlated with MetS (B (95% CI) = 0.29 (0.21,0.37) for QA), and FLI (B (95% CI) = 0.30 (0.21,0.39) for QA).Higher plasma concentrations of KYN pathway metabolites are associated with obesity and with increased risk for metabolic syndrome and fatty liver in prepubertal Asian children." @default.
• W4213309951 created "2022-02-24" @default.
• W4213309951 creator A5002446541 @default.
• W4213309951 creator A5011060430 @default.
• W4213309951 creator A5011338575 @default.
• W4213309951 creator A5024814922 @default.
• W4213309951 creator A5031184713 @default.
• W4213309951 creator A5055971533 @default.
• W4213309951 creator A5058979039 @default.
• W4213309951 creator A5060842156 @default.
• W4213309951 creator A5065566802 @default.
• W4213309951 creator A5072736104 @default.
• W4213309951 creator A5076848338 @default.
• W4213309951 creator A5079704313 @default.
• W4213309951 date "2022-02-16" @default.
• W4213309951 modified "2023-10-15" @default.
• W4213309951 title "Association of plasma kynurenine pathway metabolite concentrations with metabolic health risk in prepubertal Asian children" @default.
• W4213309951 cites W1479698819 @default.
• W4213309951 cites W1505887853 @default.
• W4213309951 cites W1598480899 @default.
• W4213309951 cites W1646247342 @default.
• W4213309951 cites W1650863056 @default.
• W4213309951 cites W1656265260 @default.
• W4213309951 cites W1816148962 @default.
• W4213309951 cites W1833773432 @default.
• W4213309951 cites W1969641535 @default.
• W4213309951 cites W1975123684 @default.
• W4213309951 cites W1979296983 @default.
• W4213309951 cites W2007233369 @default.
• W4213309951 cites W2011133918 @default.
• W4213309951 cites W2011588303 @default.
• W4213309951 cites W2017602185 @default.
• W4213309951 cites W2075450571 @default.
• W4213309951 cites W2079670701 @default.
• W4213309951 cites W2097854556 @default.
• W4213309951 cites W2103146327 @default.
• W4213309951 cites W2104473789 @default.
• W4213309951 cites W2108343924 @default.
• W4213309951 cites W2111946630 @default.
• W4213309951 cites W2116404316 @default.
• W4213309951 cites W2123060704 @default.
• W4213309951 cites W2123094650 @default.
• W4213309951 cites W2134557019 @default.
• W4213309951 cites W2135674854 @default.
• W4213309951 cites W2140447273 @default.
• W4213309951 cites W2148924243 @default.
• W4213309951 cites W2155128881 @default.
• W4213309951 cites W2160234571 @default.
• W4213309951 cites W2195367862 @default.
• W4213309951 cites W2209445234 @default.
• W4213309951 cites W2490410360 @default.
• W4213309951 cites W2510476194 @default.
• W4213309951 cites W2516463544 @default.
• W4213309951 cites W2518455214 @default.
• W4213309951 cites W2522936083 @default.
• W4213309951 cites W2591319179 @default.
• W4213309951 cites W2595826119 @default.
• W4213309951 cites W2598111690 @default.
• W4213309951 cites W2607031541 @default.
• W4213309951 cites W2626636841 @default.
• W4213309951 cites W2741302852 @default.
• W4213309951 cites W2762558246 @default.
• W4213309951 cites W2767488322 @default.
• W4213309951 cites W2807643570 @default.
• W4213309951 cites W2888513982 @default.
• W4213309951 cites W2891756143 @default.
• W4213309951 cites W2900369826 @default.
• W4213309951 cites W2922101672 @default.
• W4213309951 cites W2944227504 @default.
• W4213309951 cites W2964798802 @default.
• W4213309951 cites W2992356442 @default.
• W4213309951 cites W3011068798 @default.
• W4213309951 cites W3107643026 @default.
• W4213309951 cites W3107747122 @default.
• W4213309951 cites W3163204426 @default.
• W4213309951 cites W3170726490 @default.
• W4213309951 cites W3172642814 @default.
• W4213309951 cites W3181505303 @default.
• W4213309951 cites W3189162820 @default.
• W4213309951 cites W4212867161 @default.
• W4213309951 cites W623502341 @default.
• W4213309951 doi "https://doi.org/10.1038/s41366-022-01085-4" @default.
• W4213309951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35173282" @default.
• W4213309951 hasPublicationYear "2022" @default.
• W4213309951 type Work @default.
• W4213309951 citedByCount "3" @default.
• W4213309951 countsByYear W42133099512023 @default.
• W4213309951 crossrefType "journal-article" @default.
• W4213309951 hasAuthorship W4213309951A5002446541 @default.
• W4213309951 hasAuthorship W4213309951A5011060430 @default.
• W4213309951 hasAuthorship W4213309951A5011338575 @default.
• W4213309951 hasAuthorship W4213309951A5024814922 @default.
• W4213309951 hasAuthorship W4213309951A5031184713 @default.
• W4213309951 hasAuthorship W4213309951A5055971533 @default.
• W4213309951 hasAuthorship W4213309951A5058979039 @default.
• W4213309951 hasAuthorship W4213309951A5060842156 @default.
• W4213309951 hasAuthorship W4213309951A5065566802 @default.
• W4213309951 hasAuthorship W4213309951A5072736104 @default.

• next